These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
372 related articles for article (PubMed ID: 26521452)
1. [Preparation and evaluation of risperidone-loaded microsphere/sucrose acetate isobutyrate in situ forming complex depot with double diffusion barriers]. Lin X; Tang X; Xu YH; Zhang Y; Zhang Y; He HB Yao Xue Xue Bao; 2015 Jun; 50(6):775-82. PubMed ID: 26521452 [TBL] [Abstract][Full Text] [Related]
2. A Uniform Ultra-Small Microsphere/SAIB Hybrid Depot with Low Burst Release for Long-Term Continuous Drug Release. Lin X; Xu Y; Tang X; Zhang Y; Chen J; Zhang Y; He H; Yang Z Pharm Res; 2015 Nov; 32(11):3708-21. PubMed ID: 26077999 [TBL] [Abstract][Full Text] [Related]
3. Tracking the effect of microspheres size on the drug release from a microsphere/sucrose acetate isobutyrate (SAIB) hybrid depot in vitro and in vivo. Lin X; Wang J; Xu Y; Tang X; Chen J; Zhang Y; Zhang Y; Yang Z Drug Dev Ind Pharm; 2016 Sep; 42(9):1455-65. PubMed ID: 26790718 [TBL] [Abstract][Full Text] [Related]
4. A novel risperidone-loaded SAIB-PLGA mixture matrix depot with a reduced burst release: effects of solvents and PLGA on drug release behaviors in vitro/in vivo. Lin X; Yang S; Gou J; Zhao M; Zhang Y; Qi N; He H; Cai C; Tang X; Guo P J Mater Sci Mater Med; 2012 Feb; 23(2):443-55. PubMed ID: 22170300 [TBL] [Abstract][Full Text] [Related]
5. Sucrose acetate isobutyrate as an in situ forming system for sustained risperidone release. Lu Y; Yu Y; Tang X J Pharm Sci; 2007 Dec; 96(12):3252-62. PubMed ID: 17721936 [TBL] [Abstract][Full Text] [Related]
6. Improvement of the Antitumor Efficacy of Intratumoral Administration of Cucurbitacin Poly(Lactic-co-Glycolic Acid) Microspheres Incorporated in In Situ-Forming Sucrose Acetate Isobutyrate Depots. Wang JW; Xu JH; Li J; Zhao MH; Zhang HF; Liu DC; Zhou X; Xu H J Pharm Sci; 2016 Jan; 105(1):205-11. PubMed ID: 26566075 [TBL] [Abstract][Full Text] [Related]
7. Electrosprayed naringin-loaded microsphere/SAIB hybrid depots enhance bone formation in a mouse calvarial defect model. Yang X; Almassri HNS; Zhang Q; Ma Y; Zhang D; Chen M; Wu X Drug Deliv; 2019 Dec; 26(1):137-146. PubMed ID: 30799644 [TBL] [Abstract][Full Text] [Related]
8. In vitro study of lysozyme in poly(lactide-co-glycolide) microspheres with sucrose acetate isobutyrate. Lee ES; Kwon MJ; Lee H; Na K; Kim JJ Eur J Pharm Sci; 2006 Dec; 29(5):435-41. PubMed ID: 16978848 [TBL] [Abstract][Full Text] [Related]
9. Novel injectable progesterone-loaded nanoparticles embedded in SAIB-PLGA in situ depot system for sustained drug release. Cao Z; Tang X; Zhang Y; Yin T; Gou J; Wang Y; He H Int J Pharm; 2021 Sep; 607():121021. PubMed ID: 34416333 [TBL] [Abstract][Full Text] [Related]
10. Electrosprayed minocycline hydrochloride-loaded microsphere/SAIB hybrid depot for periodontitis treatment. Zhang T; Qiu Y; Song J; Zhou P; Liao H; Cheng Y; Wu X Drug Deliv; 2021 Dec; 28(1):620-633. PubMed ID: 33779441 [TBL] [Abstract][Full Text] [Related]
11. Formation Mechanism and In Vitro Evaluation of Risperidone-Containing PLGA Microspheres Fabricated by Ultrafine Particle Processing System. Huang Z; Chen X; Fu H; Wen X; Ma C; Zhang J; Wu C; Huang Y; Pan X; Wu C J Pharm Sci; 2017 Nov; 106(11):3363-3371. PubMed ID: 28736289 [TBL] [Abstract][Full Text] [Related]
12. Effects of formulation parameters on encapsulation efficiency and release behavior of risperidone poly(D,L-lactide-co-glycolide) microsphere. Su Z; Sun F; Shi Y; Jiang C; Meng Q; Teng L; Li Y Chem Pharm Bull (Tokyo); 2009 Nov; 57(11):1251-6. PubMed ID: 19881277 [TBL] [Abstract][Full Text] [Related]
13. Delivery of radix ophiopogonis polysaccharide via sucrose acetateisobutyrate-based in situ forming systems alone or combined with itsmono-PEGylation. Wang L; Zheng X; Wu F; Shen L; Lin X; Feng Y Drug Deliv; 2018 Nov; 25(1):267-277. PubMed ID: 29334805 [TBL] [Abstract][Full Text] [Related]
14. An Accelerated Release Method of Risperidone Loaded PLGA Microspheres with Good IVIVC. Hu X; Zhang J; Tang X; Li M; Ma S; Liu C; Gao Y; Zhang Y; Liu Y; Yu F; Yang Y; Guo J; Li Z; Mei X Curr Drug Deliv; 2018; 15(1):87-96. PubMed ID: 28521697 [TBL] [Abstract][Full Text] [Related]
15. Raloxifene-/raloxifene-poly(ethylene glycol) conjugate-loaded microspheres: A novel strategy for drug delivery to bone forming cells. Kavas A; Keskin D; Altunbaş K; Tezcaner A Int J Pharm; 2016 Aug; 510(1):168-83. PubMed ID: 27343363 [TBL] [Abstract][Full Text] [Related]
16. Sustained release of risperidone from biodegradable microspheres prepared by in-situ suspension-evaporation process. An T; Choi J; Kim A; Lee JH; Nam Y; Park J; Sun Bk; Suh H; Kim CJ; Hwang SJ Int J Pharm; 2016 Apr; 503(1-2):8-15. PubMed ID: 26899975 [TBL] [Abstract][Full Text] [Related]
17. Effect of bases with different solubility on the release behavior of risperidone loaded PLGA microspheres. Hu Z; Liu Y; Yuan W; Wu F; Su J; Jin T Colloids Surf B Biointerfaces; 2011 Aug; 86(1):206-11. PubMed ID: 21524893 [TBL] [Abstract][Full Text] [Related]
18. Influence of drying processes on the structures, morphology and Wu Z; Zhao M; Zhang W; Yang Z; Xu S; Shang Q J Microencapsul; 2019 Jan; 36(1):21-31. PubMed ID: 30757946 [TBL] [Abstract][Full Text] [Related]
19. In vitro-in vivo correlation of parenteral PLGA microspheres: Effect of variable burst release. Andhariya JV; Jog R; Shen J; Choi S; Wang Y; Zou Y; Burgess DJ J Control Release; 2019 Nov; 314():25-37. PubMed ID: 31654687 [TBL] [Abstract][Full Text] [Related]
20. Microsphere delivery of Risperidone as an alternative to combination therapy. D'Souza S; Faraj J; DeLuca P Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]